38° Rain

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

10.23 -1.21 (-10.58%)

Streaming Delayed Price Updated: 3:19 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

The Implications Behind Genetron Health's Latest Earnings Report ↗

December 08, 2021

Genetron Holdings Limited (NASDAQ: GTH) recently announced its latest fiscal report, elaborating its progress in the oncology genetic testing industry. The China-based company provides early tumor...

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 07, 2021

Gainers PLx Pharma (NASDAQ:PLXP) stock in...

Via Benzinga

Analyst Ratings For NeoGenomics ↗

December 07, 2021

Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following...

Via Benzinga

The Implications Behind Genetron Health's Latest Earnings Report ↗

December 03, 2021

Image provided by Mentor Finance Genetron Holdings Limited (NASDAQ: GTH) recently announced its latest fiscal report, elaborating its progress in the oncology genetic testing...

Via Benzinga

NeoGenomics To Participate In The Stephens Annual Investment Conference 2021

November 30, 2021

FT. MYERS, FL / ACCESSWIRE / November 30, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

Where NeoGenomics Stands With Analysts ↗

November 05, 2021

Over the past 3 months, 4 analysts have published their opinion on NeoGenomics (NASDAQ:

Via Benzinga

Recap: NeoGenomics Q3 Earnings ↗

November 04, 2021

NeoGenomics (NASDAQ:NEO) reported its Q3 earnings results on Thursday, November 4, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

NASDAQ: NEO Shareholder Notice: Investigation over Potential Wrongdoing at NeoGenomics, Inc. ↗

November 29, 2021

San Diego, CA -- (SBWIRE) -- 11/29/2021 -- An investigation on behalf of investors in NeoGenomics, Inc. (NASDAQ: NEO) shares over potential wrongdoing at NeoGenomics, Inc. was announced.

Via SBWire

NASDAQ:NEO Investor Notice: Investigation over Possible Securities Laws Violations by NeoGenomics, Inc. ↗

November 10, 2021

San Diego, CA -- (SBWIRE) -- 11/10/2021 -- NeoGenomics, Inc. is under investigation concerning possible violations of securities laws in connection with certain financial statements.

Via SBWire

NeoGenomics Appoints Dave Daly to Its Board of Directors

November 10, 2021

FT. MYERS, FL / ACCESSWIRE / November 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, has...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NeoGenomics, inc (NEO) Q3 2021 Earnings Call Transcript ↗

November 06, 2021

NEO earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

NeoGenomics Reports Revenue of $121 Million in the Third Quarter

November 04, 2021

Third-Quarter 2021 Results and Highlights: - Consolidated revenue of $121 million, comprised of Clinical Services revenue of $102 million and Pharma Services revenue of $19 million - Consolidated...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance Retirement

Recap: NeoGenomics Q2 Earnings ↗

August 06, 2021

Shares of NeoGenomics (NASDAQ:NEO) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 75.00% year over year to ($0.01),...

Via Benzinga

81 Biggest Movers From Yesterday ↗

November 05, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8...

Via Benzinga

55 Stocks Moving In Thursday's Mid-Day Session ↗

November 04, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday. NerdWallet, Inc. (NASDAQ: NRDS) jumped 60% to $28.86 after the...

Via Benzinga

NeoGenomics Announces Leadership Team Transition

November 04, 2021

FT. MYERS, FL / ACCESSWIRE / November 4, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays

October 19, 2021

Two clinical studies including interventional RaDaR™ study FT. MYERS, FL / ACCESSWIRE / October 19, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 ↗

October 14, 2021

Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX:

Via Benzinga

NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021

October 13, 2021

FT. MYERS, FL / ACCESSWIRE / October 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NeoGenomics Announces Board of Directors' Transition

October 12, 2021

Appoints Lead Independent Director Lynn Tetrault as Non-Executive Chair. Douglas VanOort steps-down as Executive Chairman and will retire from the Board of Directors before the end of the year FT....

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance Retirement

Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg ↗

October 04, 2021

Guardant Health Inc (NASDAQ: GH) has decided not to pursue a potential acquisition of NeoGenomics Inc (NASDAQ: NEO), Bloomberg reported citing people...

Via Benzinga

Why Guardant Health Is Down More Than 14% Friday ↗

October 01, 2021

Investors aren't fans of an acquisition the diagnostics company is rumored to be considering.

Via The Motley Fool

Guardant Health Weighing NeoGenomics Acquisition: Bloomberg ↗

October 01, 2021

Bloomberg reported that Guardant Health Inc (NASDAQ: GH) is reportedly exploring an acquisition of NeoGenomics Inc (NASDAQ: NEO), citing people familiar...

Via Benzinga

NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021

September 09, 2021

FT MYERS, FL / ACCESSWIRE / September 9, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

September 01, 2021

FT. MYERS, FL / ACCESSWIRE / September 1, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

Earnings Scheduled For August 12, 2021 ↗

August 12, 2021

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...

Via Benzinga

NeoGenomics, inc (NEO) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

NEO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

NeoGenomics Q2 Earnings Helped By Higher Test Volume; Backs FY21 Guidance ↗

August 06, 2021

NeoGenomics Inc (NASDAQ: NEO) reported Q2 revenue of $122 million, +40% Y/Y, beating the consensus of $118.16 million. Clinical Services revenue of $101 million...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

NeoGenomics, Inc. - Common Stock (NQ:NEO)

All News about NeoGenomics, Inc. - Common Stock

Sections

Services